New mRNA vaccine could reduce the recurrence and spread of skin cancer
Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
We haven't written up this one. NPR Health has the full story — the link below goes straight to it.